Cite
MLA Citation
Ahmad Tarhini et al.. “312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A339. http://access.bl.uk/ark:/81055/vdc_100144711261.0x000001